Is Mersana Therapeutics Inc (MRSN) Stock a good value investment?

JP Morgan raised the price target for the Mersana Therapeutics Inc (NASDAQ:MRSN) stock from “an Underweight” to “a Neutral”. The rating was released on March 19, 2024, according to finviz. We previously noted in another research note published on February 29, 2024 by Wedbush that upgraded the stock from a Neutral to an Outperform with […]

Mersana Therapeutics Inc (NASDAQ:MRSN) Stock Price Advanced 2.42% to $3.81

JP Morgan raised the price target for the Mersana Therapeutics Inc (NASDAQ:MRSN) stock from “an Underweight” to “a Neutral”. The rating was released on March 19, 2024, according to finviz. We previously noted in another research note published on February 29, 2024 by Wedbush that upgraded the stock from a Neutral to an Outperform with […]

Are you thinking about selling now? Mersana Therapeutics Inc (MRSN) Stock

JP Morgan raised the price target for the Mersana Therapeutics Inc (NASDAQ:MRSN) stock from “an Underweight” to “a Neutral”. The rating was released on March 19, 2024, according to finviz. We previously noted in another research note published on February 29, 2024 by Wedbush that upgraded the stock from a Neutral to an Outperform with […]

Why Mersana Therapeutics Inc (NASDAQ:MRSN) Stock went up 9.27% in Last Year?

JP Morgan raised the price target for the Mersana Therapeutics Inc (NASDAQ:MRSN) stock from “an Underweight” to “a Neutral”. The rating was released on March 19, 2024, according to finviz. We previously noted in another research note published on February 29, 2024 by Wedbush that upgraded the stock from a Neutral to an Outperform with […]

Is this a gain, a loss, or a throwaway? Mersana Therapeutics Inc (MRSN) Stock

JP Morgan raised the price target for the Mersana Therapeutics Inc (NASDAQ:MRSN) stock from “an Underweight” to “a Neutral”. The rating was released on March 19, 2024, according to finviz. We previously noted in another research note published on February 29, 2024 by Wedbush that upgraded the stock from a Neutral to an Outperform with […]